Action 6826 SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Shanghai Haohai Biological Technology Co., Ltd.

Actions

6826

CNE100001W69

Temps Différé Hong Kong S.E.
Autres places de cotation
 08:36:10 30/04/2024 		Varia. 5j. Varia. 1 janv.
41 HKD -1,32% Graphique intraday de Shanghai Haohai Biological Technology Co., Ltd. +7,18% +1,86%
11/03 Les bénéfices de Shanghai Haohai pour 2023 augmentent grâce à la hausse des revenus ; les actions progressent de 5%. MT
23/02 Shanghai Haohai Biological Technology Co. publie ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Shanghai Haohai's 2023 Profit Rises on Higher Revenue; Shares Rise 5%
Shanghai Haohai Biological Technology Co., Ltd. Proposes Final Dividend for the Year Ended December 31, 2023, Payable on July 19, 2024
Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Shanghai Haohai Biological Forecasts Up to 138% Boost in 2023 Profit
Shanghai Haohai Biological Technology Co., Ltd. Provides Preliminary Unaudited Consolidated Group Earnings Guidance for the Year Ended 31 December 2023
Tranche Update on Shanghai Haohai Biological Technology Co., Ltd.'s Equity Buyback Plan announced on September 27, 2023.
Shanghai Haohai Biological Technology Co., Ltd. Announces Resignation of Guo Yongqing as Independent Non-Executive Director, Chairman of Audit Committee, Member of Remuneration and Appraisal Committee and Member of Nomination Committee
Haohai Biological Technology's Q3 Profit Rises 34%; Hong Kong Shares Jump 5%
Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tranche Update on Shanghai Haohai Biological Technology Co., Ltd.'s Equity Buyback Plan announced on September 27, 2023.
Shanghai Haohai Biological Technology Co., Ltd. commences an Equity Buyback Plan for 1,538,461 shares, representing 0.9% for CNY 200 million, under the auhtorization approved on September 15, 2023.
Shanghai Haohai Biological Technology to See Rise in January-September Profit
Shanghai Haohai Biological Technology Co., Ltd. Provides Unaudited Consolidated Financial Guidance for the Nine Months Ended 30 September 2023
Shanghai Haohai Biological Technology's Profit Surges 188.9% in H1; Shares Up 3%
Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Shanghai Haohai Biological Technology Co., Ltd. authorizes a Buyback Plan.
Shanghai Haohai Biological to Buy Remaining Stake in Medical Aesthetics, Cosmetology Business
Shanghai Haohai Biological Technology Co., Ltd. entered into the equity transfer agreement to acquire 36.3636% stake in OHMK Medical Technology Co., Ltd. from Tianjin Huacan Enterprise Management Consulting Partnership, Shanghai Ermei Enterprise Management Consulting Partnership, Yuan Yibing, Lian Songyong and Chen Guangfei for approximately CNY 150 million.
Shanghai Haohai Biological Technology’s H1 Profit to See Up to 210% Boost
Shanghai Haohai Biological Technology Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2023
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 6826
  4. Actualités Shanghai Haohai Biological Technology Co., Ltd.
  5. Autres langues